Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Mar 5, 2014
Insider Transaction Report
Form 4
Mirovsky Pavel
President of Valeant Europe
Transactions
- Award
Non-Qualified Stock Options (right to purchase)
2014-03-03+71,625→ 71,625 totalExercise: $144.86From: 2018-03-03Exp: 2024-03-03→ Common Shares, no par value (71,625 underlying)
Footnotes (1)
- [F1]The options vest one-fourth per year for four years starting from the date of grant with the first vest date falling on the first anniversary of the grant, the second vest date falling on the second anniversary of the grant, the third vest date falling on the third anniversary of the grant, and the fourth vest date falling on the fourth anniversary of the grant.